Neurofeedback Training for Managing Neuropathic Pain–Like Features in Chronic Musculoskeletal Pain: Protocol for an Open-Label Pilot Feasibility Clinical Trial
JMIR Research Protocols · 2025
DOI: 10.2196/78806 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift JMIR Research Protocols, 2025. Verfasst von Luke Spencer Bialostocki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, Faculty of Biomedical Sciences, University of Otago, Dunedin, New Zealand. Hauptthemen laut MEDLINE: Chronic Pain, Musculoskeletal Pain, Neuralgia, Neurofeedback. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Neuropathic pain (NP) is characterized as pain arising from lesions of the somatosensory nervous system. However, NP-like features have been found in several chronic secondary musculoskeletal (MSK) pain conditions in the absence of detectable lesion or damage to the somatosensory pathways. Emerging evidence has demonstrated associations between NP-like symptoms and altered neural activity within brain regions implicated in sensory perception and affective-emotional processing of pain with consistent findings of abnormal activity in the right insula (RIns) cortex and dorsal anterior cingulate cortex (dACC). Electroencephalography neurofeedback (EEG-NF) is a brain-computer interface biofeedback technique that allows individuals to self-regulate the real-time cortical brain activities of the regions of interest.
Objective
The primary objective of this study is to investigate the feasibility and safety of a novel EEG-NF intervention designed to simultaneously downtrain activity in the RIns and dACC in individuals with a chronic secondary MSK pain condition exhibiting NP-like features. In addition, this study will conduct secondary exploratory analyses to investigate EEG-derived neuronal changes and their associations with clinical and experimental pain outcomes following the EEG-NF training.
Methods
We will design a single-arm, open-label, pilot-feasibility trial. We will recruit adults aged 35-75 years with a score of ≥19 using the PainDETECT questionnaire and an average pain score of ≥4 on the 11-point Numeric Pain Rating Scale over the last 3 months, with a minimum pain duration of 3 months, to receive active EEG-NF training. Participants will receive auditory feedback as a reward for achieving a predetermined activity threshold of the RIns and dACC. Primary outcomes will evaluate feasibility, acceptability, and safety using both self-reported questionnaires and monitoring data. Collected data will be summarized descriptively, with mean (SD) reported where appropriate. Secondary outcomes will include EEG parameters, self-reported measures, heart rate variability, and quantitative sensory testing. An exploratory within-group pre-post statistical comparison will be conducted for all secondary outcome measures, and correlation analysis will be performed to explore relationships between EEG measures, self-reported outcomes, heart rate variability, and quantitative sensory testing measures.
Results
This study has received approval from the Health and Disability Ethics Committee and is registered with the Australian New Zealand Clinical Trials Registry. Participant recruitment began in April 2025 and is ongoing. As of October 2025, data collection has been completed, with a total of 5 participants enrolled, all of whom have completed the study to date. We expect to complete the study in March 2026. This study will generate data on feasibility, safety, acceptability, and preliminary data to inform a fully powered effectiveness clinical trial.
Conclusions
The results and data generated will inform the design and sample size calculation for a fully powered randomized controlled trial aimed at evaluating the effectiveness of EEG-NF in targeting NP-like features in individuals with chronic MSK pain. Trial Registration Australian New Zealand Clinical Trials Registry ACTRN12625000706471; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=389568&isReview=true International Registered Report Identifier (IRRID) DERR1-10.2196/78806
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anatomy, Faculty of Biomedical Sciences, University of Otago, Dunedin, New Zealand.
- Department of Surgical Sciences, Faculty of Medicine, University of Otago, Dunedin, New Zealand.
- Neurofeedback Services of New York, New York, NY, United States.
- Centre for Health, Activity, and Rehabilitation Research, School of Physiotherapy, University of Otago, Dunedin, New Zealand.
ORCID-Profile: Luke Spencer Bialostocki, Divya Bharatkumar Adhia, Damith Rathnayake Mudiyanselage, Mark Llewellyn Smith, Yusuf Ozgur Cakmak, Dirk De Ridder, Ramakrishnan Mani, Jerin Mathew
Zitieren
APA
Bialostocki, L. S., Adhia, D. B., Mudiyanselage, D. R., Smith, M. L., Cakmak, Y. O., De Ridder, D., Mani, R., & Mathew, J. (2025). Neurofeedback Training for Managing Neuropathic Pain–Like Features in Chronic Musculoskeletal Pain: Protocol for an Open-Label Pilot Feasibility Clinical Trial. JMIR Research Protocols. https://doi.org/10.2196/78806
Vancouver
Bialostocki LS, Adhia DB, Mudiyanselage DR, Smith ML, Cakmak YO, De Ridder D, et al. Neurofeedback Training for Managing Neuropathic Pain–Like Features in Chronic Musculoskeletal Pain: Protocol for an Open-Label Pilot Feasibility Clinical Trial. JMIR Research Protocols. 2025. doi:10.2196/78806
BibTeX
@article{Bialostocki2025,
author = {Bialostocki, Luke Spencer and Adhia, Divya Bharatkumar and Mudiyanselage, Damith Rathnayake and Smith, Mark Llewellyn and Cakmak, Yusuf Ozgur and De Ridder, Dirk and Mani, Ramakrishnan and Mathew, Jerin},
title = {Neurofeedback Training for Managing Neuropathic Pain–Like Features in Chronic Musculoskeletal Pain: Protocol for an Open-Label Pilot Feasibility Clinical Trial},
journal = {JMIR Research Protocols},
year = {2025},
doi = {10.2196/78806}
}
EUVIMED